Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Extracorporeal Photopheresis as Immunomodulatory Therapy of Subclinical Antibody-mediated Rejection After Lung Transplantation: a Prospective RCT

NCT06112951 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT06112951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06112951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Extracorporeal Photopheresis as Immunomodulatory Therapy of Subclinical Antibody-mediated Rejection After Lung Transplantation: a Prospective RCT
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2024
Completion date
June 1, 2027
Enrollment
80 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

antibody-mediated rejection, lung transplant rejection